Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Everolimus in Participants With Previously Treated Advanced ccRCC"

145 views
October 25, 2023
Comments 0
Login to view comments. Click here to Login